This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.
Patients undergoing the procedures due to infection, chronic limb-threatening ischemia and other serious complications may not be receiving the follow-up care their need.
Nurses are struggling to accept workplace assistance from AI. Not all, of course, but enough of them that those who appear to be resisting the relentless march of progress catch the public’s eye.
Utah made waves last month when the state announced it would let an AI chatbot autonomously order drugs for patients. The move struck some observers as something of a high-stakes gamble.
The January employment situation summary, released Feb. 11 by the Bureau of Labor Statistics, shows an American economy leaning heavily on healthcare to put jobseekers to work.
The Department of Health and Human Services has unfurled a roadmap for aligning its approach to AI adoption in healthcare with the broad AI aspirations of President Trump.
HHS’s 340B drug discount program is set to shift to a rebate model on New Year’s Day. But a lawsuit and temporary restraining order filed by the AHA and others may block the change from going live on time.
Will there or won’t there be a federal moratorium on state-level regulation of AI?That’s only one question healthcare stakeholders are asking as 2025’s time begins running out.
Advanced AI technologies are starting to play a bigger role in TAVR care, helping cardiologists plan ahead, make critical decisions and predict potential complications. Looking to the future, though, it is clear this is just the beginning.
Hospitals could be turning away high-risk heart patients to help their TAVR programs receive a higher ranking, according to new research published in JACC: Cardiovascular Interventions.